BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06431022 updates: 1. completion date: 2026-05-10 → 2026-06-05 2. primary completion date: 2026-05-10 → 2026-06-05
Clinical trial NCT06431022 updates: 1. completion date: 2026-05-10 → 2026-06-05 2. primary completion date: 2026-05-10 → 2026-06-05
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical